Sinopharm Group Co's total assets for Q4 2025 were ¥390.61B, a decrease of -7.03% from the previous quarter. SHTDY total liabilities were ¥256.36B for the fiscal quarter, a -11.81% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.